These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35287527)

  • 1. Advances in pharmacotherapy for acute kidney injury.
    Xu Y; Zou P; Cao X
    Expert Opin Pharmacother; 2022 Apr; 23(6):713-726. PubMed ID: 35287527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute kidney injury: emerging pharmacotherapies in current clinical trials.
    Benoit SW; Devarajan P
    Pediatr Nephrol; 2018 May; 33(5):779-787. PubMed ID: 28601936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs in Development for Acute Kidney Injury.
    Hulse M; Rosner MH
    Drugs; 2019 Jun; 79(8):811-821. PubMed ID: 31004331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the pharmacological management of sepsis-associated acute kidney injury.
    Kalantari K; Rosner MH
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1401-1411. PubMed ID: 34493146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent efficacy of Stachybotrys microspora triprenyl phenol-7, a small molecule having anti-inflammatory and antioxidant activities, in a mouse model of acute kidney injury.
    Shibata K; Hashimoto T; Hasumi K; Nobe K
    Eur J Pharmacol; 2021 Nov; 910():174496. PubMed ID: 34506776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Inflammation and Oxidative Stress as a Therapy for Ischemic Kidney Injury.
    Andrianova NV; Zorov DB; Plotnikov EY
    Biochemistry (Mosc); 2020 Dec; 85(12):1591-1602. PubMed ID: 33705297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging therapeutic strategies for transplantation-induced acute kidney injury: protecting the organelles and the vascular bed.
    Melis N; Thuillier R; Steichen C; Giraud S; Sauvageon Y; Kaminski J; Pelé T; Badet L; Richer JP; Barrera-Chimal J; Jaisser F; Tauc M; Hauet T
    Expert Opin Ther Targets; 2019 Jun; 23(6):495-509. PubMed ID: 31022355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nilotinib ameliorates folic acid-induced acute kidney injury through modulation of TWEAK and HSP-70 pathways.
    Zaghloul MS; Abdelrahman RS
    Toxicology; 2019 Nov; 427():152303. PubMed ID: 31593741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent early clinical drug development for acute kidney injury.
    Gallagher KM; O'neill S; Harrison EM; Ross JA; Wigmore SJ; Hughes J
    Expert Opin Investig Drugs; 2017 Feb; 26(2):141-154. PubMed ID: 27997816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drugs for acute kidney injury.
    Côté JM; Murray PT; Rosner MH
    Curr Opin Crit Care; 2020 Dec; 26(6):525-535. PubMed ID: 33027145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic action of bone marrow-derived stem cells against acute kidney injury.
    Liu P; Feng Y; Wang Y; Zhou Y
    Life Sci; 2014 Oct; 115(1-2):1-7. PubMed ID: 25219881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diosmetin alleviates acute kidney injury by promoting the TUG1/Nrf2/HO-1 pathway in sepsis rats.
    Wang W; Zhang S; Yang F; Xie J; Chen J; Li Z
    Int Immunopharmacol; 2020 Nov; 88():106965. PubMed ID: 33182044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria as therapeutic targets in acute kidney injury.
    Hall AM; Schuh CD
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):355-62. PubMed ID: 27166518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria: a therapeutic target in acute kidney injury.
    Ishimoto Y; Inagi R
    Nephrol Dial Transplant; 2016 Jul; 31(7):1062-9. PubMed ID: 26333547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the development of animal models of acute kidney injury and its impact on drug discovery.
    Sanz AB; Sanchez-Niño MD; Martín-Cleary C; Ortiz A; Ramos AM
    Expert Opin Drug Discov; 2013 Jul; 8(7):879-95. PubMed ID: 23627598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced efficiency of mitochondria-targeted peptide SS-31 for acute kidney injury by pH-responsive and AKI-kidney targeted nanopolyplexes.
    Liu D; Jin F; Shu G; Xu X; Qi J; Kang X; Yu H; Lu K; Jiang S; Han F; You J; Du Y; Ji J
    Biomaterials; 2019 Aug; 211():57-67. PubMed ID: 31085359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and autophagy: crucial modulators of kidney injury.
    Sureshbabu A; Ryter SW; Choi ME
    Redox Biol; 2015; 4():208-14. PubMed ID: 25613291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 4: An attractive therapeutic target for acute kidney injury.
    Jha AK; Gairola S; Kundu S; Doye P; Syed AM; Ram C; Murty US; Naidu VGM; Sahu BD
    Life Sci; 2021 Apr; 271():119155. PubMed ID: 33548286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of vitamin E against acute kidney injury.
    Liu P; Feng Y; Wang Y; Zhou Y; Zhao L
    Biomed Mater Eng; 2015; 26 Suppl 1():S2133-44. PubMed ID: 26405992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury?
    Koyner JL; Sher Ali R; Murray PT
    Nephron Exp Nephrol; 2008; 109(4):e109-17. PubMed ID: 18802373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.